# K093366: Nmi Picc II

- Pathway: 510(k) (Special)
- Applicant: Navilyst Medical, Inc.
- Decided: Nov 24, 2009 after 26 days
- Product code: LJS (Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days)
- Device class: 2
- Regulation: 21 CFR 880.5970
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K041420 (2004). 5 ancestors in all.
26 later devices descend from it; 5 cite it directly.
1 of 32 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K091261: Nmi Picc, Navilyst Medical, Inc. (2009) Summary page 1.
- K070002: Boston Scientific Peripherally Inserted Central Catheter, Boston Scientific (2007) Summary page 1.
- K021704: Vaxcel Picc with Pasv Valve Technology, Catheter Innovations, Inc. (2002) Summary page 1.

## Most influential descendants
- K121089: Nmi Picc Iii (2012), 23 descendants of its own
- K111906: Xcela Hybrid Picc with Pasv Valve Technology (2011), 14 descendants of its own
- K122882: Nmi Hpicc Iii (2012), 12 descendants of its own
- K131942: Nmi Picc Iii Catheter, Nmi Hpicc Iii Catheter (2013), 7 descendants of its own
- K133264: Nmi Picc Iii (2013), 6 descendants of its own

## Indications for use
For short or long-term peripheral access to tile central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media.

Source page: https://510kreport.com/device/K093366
Methodology: https://510kreport.com/methodology